CXMT's $4.3 billion IPO tests Zhu Yiming's China memory bet

The Hefei DRAM maker is seeking China's largest A-share IPO of 2026 as AI demand and U.S. controls push Beijing toward domestic memory.

By ยท Published

Why it matters

CXMT's IPO is a market test for China's semiconductor self-sufficiency: investors are being asked to fund domestic DRAM capacity while U.S. rules and AI demand reshape the memory supply chain.

Miniature diorama of CXMT's IPO and China's domestic memory ambition amidst global tech competition (Museum-diorama miniature - handcrafted figurines, painted backdrop, and miniature props constructed from matte paper, fine wires, and subtl

Zhu Yiming's ChangXin Memory Technologies is preparing to launch a Shanghai STAR Market IPO next week that could raise about 29.5 billion yuan, or roughly $4.3 billion, turning a company founded in 2016 into the public-market test case for China's push to build its own memory supply.

Bloomberg reported on July 9th, 2026 that CXMT, which is listing as CXMT Corp., is seeking upward of $4.3 billion and would make the offering China's biggest IPO of 2026. Xinhua, in a June 15th item carried by China's State Council Information Office, said Chinese securities regulators had approved the IPO registration and that the deal would be the largest A-share IPO this year and the second-largest in STAR Market history.

The capital raise matters because CXMT is trying to solve two shortages at once. The first is commercial: AI servers are swallowing advanced memory supply, and the global DRAM incumbents have spent the past year pushing harder into high-bandwidth memory for accelerators. The second is political: Washington has tightened export and procurement rules around Chinese semiconductor supply chains, forcing Beijing to back domestic substitutes in the categories that determine whether AI infrastructure can scale inside China.

Zhu is the reason CXMT is more than another state-backed semiconductor project. A Future Science Prize donor profile describes him as founder and chairman of CXMT and founder and chairman of GigaDevice Semiconductor. The same profile says he holds degrees from Tsinghua University and a master's degree from Stony Brook University in New York. A Future Forum profile says Zhu co-founded GigaDevice in Beijing in 2005 after senior technical roles at U.S. memory companies, and that GigaDevice became a major SPI NOR Flash supplier before Zhu moved deeper into DRAM.

That biography is central to the IPO. Memory is a cycle business with brutal capital needs, long learning curves and few forgiving customers. Zhu's bet was that China could build a domestic DRAM producer with enough technical depth, state support and customer pull to survive against Samsung Electronics, SK hynix and Micron, the companies that define the category globally. CXMT is about to ask public investors to fund the next stage of that bet.

From startup to national memory supplier

CXMT's own company page says it was founded in 2016 and manufactures DRAM chips for mobile phones, PCs, tablets, servers and other products. CXMT says its work spans DRAM design, manufacturing, sales and R&D, and its company timeline says it taped out 8Gb DDR4 for manufacturing in July 2018, tested DDR4 successfully in May 2019, announced 8Gb DDR4 for mass production in September 2019 and received its first order in November 2019.

That timeline shows why the planned IPO is unusual. In less than a decade, CXMT has moved from a commercial startup in Hefei to the center of China's memory strategy. A Shanghai Stock Exchange English-language item, citing CXMT's prospectus, said the company's IPO application had passed review in May and that it planned to raise 29.5 billion yuan. The same item said CXMT had become China's largest DRAM maker and the world's fourth-largest DRAM supplier based on capacity, shipments and sales revenue, though those claims ultimately trace to company prospectus disclosures.

Bloomberg's July 9th feature adds the timing pressure: CXMT had shown what Bloomberg described as industry-leading seven-fold revenue growth in the first half, as memory shortages sharpened the need for non-Samsung, non-SK hynix and non-Micron supply. Bloomberg does not disclose CXMT's base revenue figure, profitability, yield, wafer capacity or IPO valuation, so those numbers are not included here.

The money will not make CXMT the technological peer of the global leaders overnight. A single advanced fab can consume billions of dollars before it produces reliable volume. DRAM makers win through process discipline, packaging, yield, customer qualification and timing the cycle. CXMT's raise gives Zhu more room to build capacity and fund process upgrades, but public shareholders will also inherit the volatility that makes memory different from software: average selling prices can move fast, and a capacity mistake can punish even the best-run suppliers.

The opening is in ordinary DRAM, not HBM leadership

The cleanest way to read CXMT's market opening is through what its rivals are prioritizing. Samsung Semiconductor said in February that it had begun mass production of HBM4 and shipped commercial products to customers. SK hynix said in September 2025 that it had completed HBM4 development and prepared mass production. Micron said in March that its HBM4 36GB 12H was in high-volume production and designed for Nvidia Vera Rubin.

Those announcements put the incumbents' capital and engineering attention at the high end of AI memory. CXMT's immediate opportunity sits in the wider DRAM market that feeds PCs, smartphones, servers and domestic Chinese cloud infrastructure. If leading suppliers tilt capacity and customer focus toward HBM, buyers of more standard DRAM have a reason to qualify alternatives, especially inside China.

That is the wedge Zhu needs. CXMT does not have to beat Samsung, SK hynix and Micron at HBM4 to become strategically important. It has to produce enough credible DDR and LPDDR memory, at enough volume, for Chinese device makers and cloud buyers to reduce exposure to foreign suppliers. Bloomberg frames CXMT as built to dodge US curbs. CXMT's value to Beijing is measured in substitution as much as technical ranking.

The constraint is proof. The available material does not verify commercial HBM shipments from CXMT, named AI accelerator customers, detailed yields, or exact manufacturing node competitiveness. Those gaps matter because memory buyers qualify parts through reliability and volume, not national strategy statements. CXMT can benefit from a tight cycle, but it still has to clear the same operational bar every DRAM supplier faces.

Washington remains part of the cap table

The IPO is also a policy story. In a January 7th, 2025 Federal Register notice, the U.S. Defense Department listed ChangXin Memory Technologies as a company it had determined qualified as a "Chinese military company" under Section 1260H of the FY2021 National Defense Authorization Act. Separately, Section 5949 of the FY2023 NDAA targets federal procurement of covered semiconductor products and services from named Chinese chip companies. A Federal Register procurement notice identifies covered semiconductor products or services from SMIC, CXMT and YMTC, and a later proposed FAR rule says the relevant prohibitions are set to become effective on December 23rd, 2027, unless an exception applies.

For U.S. government supply chains, that creates a hard ceiling on where CXMT chips can go. For Chinese buyers, it creates the opposite incentive: qualify domestic parts sooner, before geopolitical restrictions make foreign supply less predictable. That split is why CXMT can be both a restricted name in Washington and an attractive listing in Shanghai.

The IPO also gives Beijing a market mechanism for a project that private capital once struggled to underwrite on normal terms. DRAM demands years of spending before payback, and returns depend on a commodity cycle that founders cannot control. By taking CXMT public while memory demand is tight and AI infrastructure spending is high, Zhu and his backers are choosing the window when public investors can see the strategic scarcity most clearly.

The valuation remains undisclosed in the available material. So do the underwriters, anchor allocations and final pricing range. Those omissions matter because they will show whether the IPO is priced as a national champion, a cyclical memory producer, or something in between. What is already clear is the role CXMT is being asked to play: Zhu's company is becoming the public proxy for China's ability to turn semiconductor self-sufficiency from policy language into qualified parts, fab output and customer adoption.

Reader comments

Conversation for this story loads after sign-in.